Diagnostic Antibodies Market
Diagnostic Antibody detection is still?the primary approach for confirmation of Lyme borreliosis. Quantitative EIAs (enzyme immune assays) are used as a first-line test with the possibility of supplementary western blotting (WB). Specific antibodies are detectable in serum and in CSF.
This report contains market size and forecasts of Diagnostic Antibodies in Global, including the following market information:
- Global Diagnostic Antibodies Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-diagnostic-antibodies-forecast-2023-2030-651
The global Diagnostic Antibodies market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Monoclonal Antibodies Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Diagnostic Antibodies include Aytu BioScience, Inc., Agilent Technologies, Inc., Abbott, Abcam plc., Boehringer Ingelheim International GmbH, Bio-Rad Laboratories, Inc. and F. Hoffmann-La Roche Ltd., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diagnostic Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diagnostic Antibodies Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Diagnostic Antibodies Market Segment Percentages, by Type, 2022 (%)
- Monoclonal Antibodies
- polyclonal Antibodies
- Recombinant Polyclonal Antibodies
- Others
Global Diagnostic Antibodies Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Diagnostic Antibodies Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Diagnostic Centre
- Others
Global Diagnostic Antibodies Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Diagnostic Antibodies Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Diagnostic Antibodies revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Diagnostic Antibodies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Aytu BioScience, Inc.
- Agilent Technologies, Inc.
- Abbott
- Abcam plc.
- Boehringer Ingelheim International GmbH
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Comments
Post a Comment